CDC. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004-June 2005. Morbidity and Mortality Weekly Report 2005; 54: 958-961.
CDC. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004-June 2005. Morbidity and Mortality Weekly Report 2005; 54: 958-961.
3
0000240393
Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children
Marine WM, Chin TDY, Gravelle CR. Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. American Journal of Hygiene 1962; 76: 173-195.
Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine
Salk D. Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine. Reviews of Infectious Diseases 1980; 2: 243-257.
Isolation and characterization of circulating type I vaccine-derived poliovirus from sewage and stream waters in Hispaniola
Vinje J, et al. Isolation and characterization of circulating type I vaccine-derived poliovirus from sewage and stream waters in Hispaniola. Journal of Infectious Disease 2004; 189 1168-1175.
Isolation of polioviruses from sewage and their characteristics: Experience over two decades in Sweden
Bottiger M, Herrstrom E. Isolation of polioviruses from sewage and their characteristics: Experience over two decades in Sweden. Scandinavian Journal of Infectious Diseases 1992; 24: 151-155.